Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis

International Journal of Mycobacteriology

Volumn 4, Issue 2, 2015, Pages 92-96

  Mirsaeidi, Mehdi ^a   Sadikot, Ruxana T ^b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Bronchiectasis; Gender; Nontuberculous mycobacteria; Woman

Indexed keywords

ADIPONECTIN; FIBRILLIN; INTERSTITIAL COLLAGENASE; LEPTIN; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA;

AGE; ATYPICAL MYCOBACTERIOSIS; BODY MASS; BRONCHIECTASIS; DISEASE ASSOCIATION; FUNNEL CHEST; HUMAN; INCIDENCE; INFECTION SENSITIVITY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM KANSASII; NONHUMAN; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCOLIOSIS; SEX DIFFERENCE; ATYPICAL MYCOBACTERIUM; DISEASE PREDISPOSITION; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PHYSIOLOGY;

CORYNEBACTERINEAE;

BRONCHIECTASIS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; SEX FACTORS;

EID: 84931572815     PISSN: 22125531     EISSN: 2212554X     Source Type: Journal    
DOI: 10.1016/j.ijmyco.2015.05.002     Document Type: Review

References (33)

1. Mirsaeidi M., Machado R.F., Garcia J.G., Schraufnagel D.E. Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study. PLoS One 2014, 9(3):e91879.
2. Prevots D.R., Shaw P.A., Strickland D., et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am. J. Respir. Crit. Care Med. 2010, 182(7):970-976.
3. Winthrop K.L., McNelley E., Kendall B., et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am. J. Respir. Crit. Care Med. 2010, 182(7):977-982.
4. Cassidy P.M., Hedberg K., Saulson A., McNelly E., Winthrop K.L. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin. Infect. Dis. 2009, 49(12):e124-e129.
5. Mirsaeidi M., Farshidpour M., Allen M.B., Ebrahimi G., Falkinham J.O. Highlight on advances in nontuberculous mycobacterial disease in North America. Biomed. Res. Int. 2014, 2014:919474.
6. Shahraki A.H., Heidarieh P., Bostanabad S.Z., et al. "Multidrug-resistant tuberculosis" may be nontuberculous mycobacteria. Eur. J. Intern. Med. 2015.
7. Aksamit T.R., Philley J.V., Griffith D.E. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. Respir. Med. 2014, 108(3):417-425.
8. Henkle E., Winthrop K.L. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin. Chest Med. 2015, 36(1):91-99.
9. Hernandez-Garduno E., Elwood R.K. Demographic risk factors of pulmonary colonization by non-tuberculous mycobacteria. Int. J. Tuberc. Lung Dis. 2010, 14(1):106-112.
10. Honda J.R., Knight V., Chan E.D. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin. Chest Med. 2015, 36(1):1-11.
11. Huitt G.A., Daley C.L. Nontuberculous mycobacteria. Clin. Chest Med. 2015, 36(1):6-7. xi-xii.
12. Mirsaeidi M., Farshidpour M., Ebrahimi G., Aliberti S., Falkinham J.O. Management of nontuberculous mycobacterial infection in the elderly. Eur. J. Intern. Med. 2014, 25(4):356-363.
13. Mirsaeidi M., Hadid W., Ericsoussi B., Rodgers D., Sadikot R.T. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int. J. Infect. Dis. 2013, 17(11):e1000-e1004.
14. Tanaka E., Amitani R., Niimi A., Suzuki K., Murayama T., Kuze F. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am. J. Respir. Crit. Care Med. 1997, 155(6):2041-2046.
15. Wickremasinghe M., Ozerovitch L.J., Davies G., et al. Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 2005, 60(12):1045-1051.
16. Marras T.K., Mehta M., Chedore P., May K., Al Houqani M., Jamieson F. Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung 2010, 188(4):289-299.
17. Khan K., Wang J., Marras T.K. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am. J. Respir. Crit. Care Med. 2007, 176(3):306-313.
18. Prevots D.R., Marras T.K. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin. Chest Med. 2015, 36(1):13-34.
19. Satyanarayana G., Heysell S.K., Scully K.W., Houpt E.R. Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infect. Dis. 2011, 11:113.
20. Hoefsloot W., van Ingen J., Andrejak C., et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur. Respir. J. 2013, 42(6):1604-1613.
21. Freeman J., Morris A., Blackmore T., Hammer D., Munroe S., McKnight L. Incidence of nontuberculous mycobacterial disease in New Zealand, 2004. NZ. Med. J. 2007, 120(1256):U2580.
22. Thomson R.M. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg. Infect. Dis. 2010, 16(10):1576-1583. On Behalf of the NTM working group at the Queensland TB Control Centre, Queensland Mycobacterial Reference Laboratory.
23. Andrejak C., Thomsen V.O., Johansen I.S., et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am. J. Respir. Crit. Care Med. 2010, 181(5):514-521.
24. Kim R.D., Greenberg D.E., Ehrmantraut M.E., et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am. J. Respir. Crit. Care Med. 2008, 178(10):1066-1074.
25. Kartalija M., Ovrutsky A.R., Bryan C.L., et al. Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am. J. Respir. Crit. Care Med. 2013, 187(2):197-205.
26. Lee S.J., Ryu Y.J., Lee J.H., Chang J.H., Shim S.S. The impact of low subcutaneous fat in patients with nontuberculous mycobacterial lung disease. Lung 2014, 192(3):395-401.
27. Tsuyuguchi K., Suzuki K., Matsumoto H., Tanaka E., Amitani R., Kuze F. Effect of oestrogen on Mycobacterium avium complex pulmonary infection in mice. Clin. Exp. Immunol. 2001, 123(3):428-434.
28. Danley J., Kwait R., Peterson D.D. Normal estrogen, but low dehydroepiandrosterone levels, in women with pulmonary Mycobacterium avium complex. A preliminary study. Ann. Am. Thorac. Soc. 2014, 11(6):908-914.
29. Chan E.D., Iseman M.D. Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease. Gend. Med. 2010, 7(1):5-18.
30. Hsieh M.H., Chou P.C., Chou C.L., et al. Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan. PLoS One 2013, 8(6):e66265.
31. Maisi P., Prikk K., Sepper R., et al. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS 2002, 110(11):771-782.
32. Karakoc G.B., Inal A., Yilmaz M., Altintas D.U., Kendirli S.G. Exhaled breath condensate MMP-9 levels in children with bronchiectasis. Pediatr. Pulmonol. 2009, 44(10):1010-1016.
33. Sakamoto K., Kim M.J., Rhoades E.R., et al. Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases. Infect. Immun. 2013, 81(3):764-776.